Search This Blog

Thursday, November 7, 2019

ZIOPHARM Oncology EPS misses by $0.34, misses on revenue

ZIOPHARM Oncology (NASDAQ:ZIOP): Q3 GAAP EPS of -$0.43 misses by $0.34.
Cash & equivalents of $88.4M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)